Showing results (371-380 of 427) with videos related to

Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathyHeather E Wheeler, Eric R Gamazon, Claudia Wing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observationBeryl McCormick, Kathryn Winter, Clifford Hudis, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2017
Periprostatic adipose inflammation is associated with high-grade prostate cancerA Gucalp, N M Iyengar, X K Zhou, et al.
The New England Journal of Medicine|January 8, 2015
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancerSara M Tolaney, William T Barry, Chau T Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyNoah D Kauff, Susan M Domchek, Tara M Friebel, et al.
Breast Cancer Research and Treatment|April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)Jennifer R Bellon, Hao Guo, William T Barry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without LapatinibLisa A Carey, Donald A Berry, Constance T Cirrincione, et al.
NPJ Breast Cancer|October 23, 2018
Molecular determinants of post-mastectomy breast cancer recurrenceKimberly S Keene, Tari King, E Shelley Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2003
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Marc L Citron, Donald A Berry, Constance Cirrincione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancerMaura N Dickler, Hope S Rugo, Carey A Eberle, et al.
Pageof 43